comparemela.com

Breast Cancer Aotearoa Coalition News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Single mum of 2 continues brave fight against stage 3 breast cancer despite misdiagnosis

Pharmac Seeks Feedback On Widening Access And Transitioning To A Biosimilar Trastuzumab

Te Pātaka Whaioranga – Pharmac is considering awarding Principal Supply to a biosimilar brand of trastuzumab (branded as Herzuma), and widening access to include those with stomach (gastric) cancer, from 1 December 2023. Consultation on the proposal .

Pharmac to switch from Herceptin to cheaper breast cancer treatment

The government's drug-buying agency says the move to a cheaper equivalent would release significant funds to invest in other medicines and widen access for stomach cancer patients.

Pharmac seeks feedback on widening access and transitioning to a biosimilar trastuzumab

Te Pātaka Whaioranga – Pharmac is considering awarding Principal Supply to a biosimilar brand of trastuzumab (branded as Herzuma), and widening access to include those with stomach (gastric) cancer, from 1 December 2023. Consultation on the proposal opens today

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.